---
figid: PMC5065302__IJMM-38-05-1433-g05
figtitle: Mechanisms through which rolipram (ROL) attenuates pain behavior in bone
  cancer pain
organisms:
- NA
pmcid: PMC5065302
filename: IJMM-38-05-1433-g05.jpg
figlink: /pmc/articles/PMC5065302/figure/f6-ijmm-38-05-1433/
number: F6
caption: Schematic diagram of the mechanisms through which rolipram (ROL) attenuates
  pain behavior in bone cancer pain. TNFR1, tumor necrosis factor receptor 1.
papertitle: The analgesic effect of rolipram is associated with the inhibition of
  the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
reftext: Chi-Hua Guo, et al. Int J Mol Med. 2016 Nov;38(5):1433-1442.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9558541
figid_alias: PMC5065302__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5065302__F6
ndex: f0a7ac8c-dec7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5065302__IJMM-38-05-1433-g05.html
  '@type': Dataset
  description: Schematic diagram of the mechanisms through which rolipram (ROL) attenuates
    pain behavior in bone cancer pain. TNFR1, tumor necrosis factor receptor 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1B
  - TNF
  - TNFRSF1A
  - IL1R1
  - PDE4B
  - MAPK8
  - MAPK9
  - MAPK10
  - CCL2
  - CCR2
---
